• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MO SCI Acquires Assets of 3M’s Advanced Materials Business

    Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets

    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece

    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability

    Machining & Laser Processing Have Huge Parts to Play in Medtech Manufacturing

    Medtech R&D Teams Must Be Creative & Resilient to Survive

    Struggling Suppliers in Electronics Manufacturing Services (EMS)

    Deep (Brain) Thoughts with Medtronic's Neuromodulation President
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Deducing the Dual Reality of Elizabeth Holmes

    The Return of the AdvaMed MedTech Conference…Live!

    Material Matters: New Materials Call for New Thinking

    5 Ways to Maintain a Talent-Centric Mindset, Even During Economic Uncertainty

    The Changing Face of UK Medical Device Regulations: Most Recent Update
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.

    NDH Medical Inc.

    JBC Technologies

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Onshoring Medical Device Manufacturing Can Strengthen Supply Chains

    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Arthur G. Russell Co. Inc., The

    LEMO USA Inc.

    NDH Medical Inc.

    JBC Technologies

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    MedTech M&A in 2023: Will It Remain a Seller’s Market?

    Compared to past years, 2022 investments are at historically average levels.

    MedTech M&A in 2023: Will It Remain a Seller’s Market?
    Florence Joffroy-Black and Dave Sheppard, MedWorld Advisors11.09.22
    As healthcare M&A advisors, we are naturally the go-to source for medtech merger and acquisition insight.

    In order to provide the best expertise, however, it is necessary to fully understand the trends affecting healthcare investments. A quick glimpse at J.P. Morgan data seems to indicate that current medtech industry investment is down, and technically it is compared with 2021. But it is important to note that last year set a healthcare financing record, thanks mainly to the continued convergence of consumer health and medical technologies. (Alphabet has partnered with Novartis on smart contact lenses, Dexcom on miniature and disposable glucose monitors, and Johnson & Johnson on surgical robots).

    Compared to past years, though, 2022 investments are at historically average levels—meaning medtech industry financing remains strong. In fact, given worldwide population demographics and the market opportunities being created by the consumer health sector, the macro future appears brighter than ever.

    But that doesn’t mean all companies will benefit from the robust financing environment. There will certainly be “winners” and “losers,” with a few heritors becoming the next health technology unicorn and some companies dropping out completely from the market (similar to a “survival of the fittest” tenet).

    Many companies will survive through consolidation because the market is not large enough to accommodate every new telemedicine upgrade, patient engagement app, electronic health record breakthrough, or wearable monitor. While the industry needs such minor incremental innovation in order to grow, the influx of these seemingly minor technologies create an investment imbalance—resulting in a glut of new players with more market opportunity in their investor decks than the market can support. Consolidation is an inevitable consequence in this set of circumstances, steering the commercial middle class to M&A (the rare unicorns and near bankrupt firms are exempt from this phenomena).

    Whether or not this investment imbalance drives medtech M&A in 2023 remains to be seen. To determine the market’s path forward next year, it is crucial to examine the trends that have impacted healthcare financing in 2022.

    Similar to overall healthcare industry investments, healthcare M&A remains historically strong in 2022. Information from Pitchbook’s Quality of Healthcare M&A Report (based on data through June 30) reveals a similar superficial dichotomy in year-over-year financing totals. Not surprisingly, this year’s sums are lower than 2021’s record highs, but investments are not down compared to historical levels.

    So, if investments this year are not diving off a cliff, does that mean M&A will continue to blossom in the next 12 months? Well, our crystal ball is as cloudy as everyone else’s; there are many factors to consider, including the still-knotted supply chain, runaway inflation, geopolitical unrest, and pricing pressures. Nevertheless, we predict M&A will remain relatively strong in 2023 for two reasons—industry consolidation and the amount of available cash for investing. Let’s take a look at both of these market drivers in more depth.

    Industry Consolidation

    As previously mentioned, significant investments over the last decade in digital and consumer health technologies have left too many players vying for the same proverbial pot of gold at the end of the market opportunity rainbow. Although the overall market is expanding, there are only a limited number of pie shares up for grabs and too many hungry stakeholders.

    The companies able to obtain a piece of the market pie will cut their own path forward either on their own, through an initial public offering, and/or by acquiring other firms to fulfill their industry and stakeholder objectives.

    However, some companies will forge a path to future success via strategic partnerships or acquisitions (becoming the M&A target rather than orchestrating a deal).

    Dry Powder (Cash Available for Investment)

    Besides emerging technology growth companies driving M&A, traditional deals for established medtech companies will remain strong in 2023. The mom and pop medical companies that have been an ongoing concern for the past 30 or 40 years are still highly sought-after assets. Those shop owners ready to sell in the next 12 months will find plenty of takers for their business.

    What drives our confidence? Simple cash economics and market segmentation.

    There are huge amounts of capital available for M&A. According to S&P Capital IQ, there is $3.7 trillion in cash and equivalents held by S&P 500 companies (as of December 2021). Additionally, there was $948 billion in cash in private equity funds as of June 2022, according to Prequin.

    The good news for potential sellers is the fact the medtech market is a highly sought-after sector by both industry strategics and private equity firms. Periods of macro uncertainty or recession have traditionally been good for healthcare investments, because of the market’s resiliency. As unfortunate as it may sound, medical conditions—particularly among the aged—are profitable for companies (cancer, for example, never bows to recession). Some sectors may lose value in a downturn but the medtech industry usually experiences a “cut in growth” of investments rather than an actual market value reduction.

    So what markets will be primed for growth in 2023? Our prediction is manufacturing, supply chain, digital health technology (especially artificial intelligence machine learning), home care, telemedicine (thanks to COVID-19), robotics, and healthcare staffing.

    Conversely, the U.S. hospital market will likely continue to struggle due to some specific revenue challenges during the transition from in-hospital care to outpatient treatment. We’ve noticed that investors are shying away from hospitals at the moment.

    Next year should produce consistent M&A activity levels due to:
    • Buyers/investors moving to more stable industries, like medtech
    • Earlier stage companies moving from fundraise mode to M&A
    • More Strategic partnerships and/or distribution deals
    Basically, 2023 should be a seller’s market for quality healthcare companies developing/commercializing products that sole a market need. There are likely to be plenty of competitive buyers looking to spend their available cash on the next unique innovation. May the best seller (and buyer) win! 


    Florence Joffroy-Black, CM&AA, is a longtime marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She currently is CEO at MedWorld Advisors and can be reached at florencejblack@medworldadvisors.com or at www.medworldadvisors.com.

    Dave Sheppard, CM&AA, is a former medical technology Fortune 500 executive and is now focused on M&A as a managing director at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com.
      Loading, Please Wait..

      Trending
      • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
      • CGM Devices Could Become Main Glucose Monitoring Solution In U.S.
      • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
      • The Future Of Biomedical Engineering Advancements
      • A New Approach To Post-Market Surveillance
      Breaking News
      • MO SCI Acquires Assets of 3M’s Advanced Materials Business
      • Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
      • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
      • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
      • LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
      View Breaking News >
      CURRENT ISSUE

      January/February 2023

      • Struggling Suppliers in Electronics Manufacturing Services (EMS)
      • Machining & Laser Processing Have Huge Parts to Play
      • Medtech R&D Teams Must Be Creative & Resilient to Survive
      • Medtronic Neuromodulation President, Nnamdi Njoku, Interview
      • 6 Ways ERP Systems Help Medical Device Manufacturers Manage Risk and Profitability
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      GOED Elects New Board Officers for 2023
      Aspire Hires Darrec Jones as VP of Business Development
      Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
      Coatings World

      Latest Breaking News From Coatings World

      PPG Completes COLORFUL COMMUNITIES Project in Denmark
      10 Partners of the Automotive Industry Form JV, Cofinity-X
      BASF Recognized as Top Company for Supplier Diversity
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      MO SCI Acquires Assets of 3M’s Advanced Materials Business
      Neurent Medical’s NEUROMARK System Becomes Commercially Available in U.S. Markets
      Aspivix's Carevix Cervical Stabilizer Gains FDA OK
      Contract Pharma

      Latest Breaking News From Contract Pharma

      Lilly 4Q Revenues Down 9% to $7.3B
      Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
      Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Pacifica Introduces Glow Baby Skincare Line
      Kohl’s Names Tom Kingsbury as Chief Executive Officer
      Mielle Unveils Haircare Bundles Inspired by Amazon Original Series Harlem
      Happi

      Latest Breaking News From Happi

      Grant Industries Names Mehran Ghadim Sales Manager, Canada
      Bio-Oil Celebrates Body Confidence Through Body Positivity Month Campaign
      Net Sales for Clorox Increase 1% for Q2 2023
      Ink World

      Latest Breaking News From Ink World

      Roland DGA Announces Key Changes to Leadership Team
      Ball Reports 2022 Results
      3D Printing Materials Market Worth $7.9 Billion by 2027: MarketsandMarkets
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      MM Packaging adds first Nilpeter press for Dublin site
      Polytag develops new UV tag reading technology
      Enterprise Print Group adds Screen Truepress Jet L350UV SAI E
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      What You’re Reading on Nonwovens-Industry.com
      Kimberly-Clark Supports Period Poverty Initiative in Australia
      Suominen Reports Q4, Full Year Results
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Toetal Solutions Secures $1.8 Million in New Financing
      Adrian Tyndall Joins Axogen's Board of Directors
      ADSM-Synchro Medical Acquired by Tyber Medical
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Zebra Provides East West Shrine Bowl with RFID Tracking Technology
      AAAS Elects Three ORNL Scientists as Fellows
      Flex Recognized as One of Fortune World’s Most Admired Companies 2023

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login